Entheon Biomedical Statistics
Total Valuation
Entheon Biomedical has a market cap or net worth of CAD 885,893. The enterprise value is 586,752.
Market Cap | 885,893 |
Enterprise Value | 586,752 |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Entheon Biomedical has 8.86 million shares outstanding. The number of shares has increased by 6.00% in one year.
Shares Outstanding | 8.86M |
Shares Change (YoY) | +6.00% |
Shares Change (QoQ) | +23.88% |
Owned by Insiders (%) | 3.27% |
Owned by Institutions (%) | n/a |
Float | 8.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 3.02 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.74 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.95
Current Ratio | 7.95 |
Quick Ratio | 7.30 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.71% and return on invested capital (ROIC) is -56.79%.
Return on Equity (ROE) | -86.71% |
Return on Assets (ROA) | -48.64% |
Return on Capital (ROIC) | -56.79% |
Revenue Per Employee | n/a |
Profits Per Employee | -337,799 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.26, so Entheon Biomedical's price volatility has been higher than the market average.
Beta (5Y) | 1.26 |
52-Week Price Change | -50.00% |
50-Day Moving Average | 0.10 |
200-Day Moving Average | 0.12 |
Relative Strength Index (RSI) | 48.13 |
Average Volume (20 Days) | 35,548 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -353,998 |
Pretax Income | -337,799 |
Net Income | -337,799 |
EBITDA | n/a |
EBIT | -353,998 |
Earnings Per Share (EPS) | -0.05 |
Balance Sheet
Cash & Cash Equivalents | 299,137 |
Total Debt | n/a |
Net Cash | 299,137 |
Net Cash Per Share | 0.03 |
Equity (Book Value) | 293,831 |
Book Value Per Share | 0.03 |
Working Capital | 288,831 |
Cash Flow
Operating Cash Flow | -351,319 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Entheon Biomedical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.00% |
Shareholder Yield | -6.00% |
Earnings Yield | -53.93% |
FCF Yield | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Mar 1, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Entheon Biomedical has an Altman Z-Score of -77. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -77 |
Piotroski F-Score | n/a |